![Heidi Hunter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 5 920 $ al 31/07/2026
Heidi Hunter is Vice Chairman at Bavarian Nordic A since 2025.
Ms. Hunter is Independent Director at Sutro Biopharma, Inc. since 2021.
Ms. Hunter is Independent Director at Vicore Pharma Holding AB since 2020.
Ms. Hunter was Independent Director at IO Biotech, Inc. from 2023 to 2026.
Ms. Hunter was Senior VP-Global Immunology Business Unit at UCB SA from 2015 to 2020.
Ms. Hunter was Senior Vice President & General Manager at Boehringer Ingelheim International GmbH from 2011 to 2015.
Ms. Hunter was Vice President at Centocor, Inc. Ms. Hunter was Vice President at IQVIA Partners A. Ms. Hunter was President at Cardinal Health Specialty Solutions from 2020 to 2022.
Ms. Hunter completed undergraduate studies at the University of Michigan.
Ms. Hunter earned an MBA from The University of Chicago Booth School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 5.000 ( 0 % ) | 5 828 $ | 31/07/2026 | |
IO BIOTECH, INC. 0,02 % | 05/06/2025 | 15.000 ( 0,02 % ) | 92 $ | 30/06/2026 |
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VICORE PHARMA HOLDING AB | Director/Miembro de la Junta | 01/01/2020 |
| SUTRO BIOPHARMA, INC. | Director/Miembro de la Junta | 19/11/2021 |
| BAVARIAN NORDIC A/S | Director/Miembro de la Junta | 01/01/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| IO BIOTECH, INC. | Director/Miembro de la Junta | 31/03/2026 |
Cardinal Health Specialty Solutions | Presidente | 01/11/2022 |
| UCB | Corporate Officer/Principal | 01/09/2020 |
Boehringer Ingelheim International GmbH
 Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals | Corporate Officer/Principal | 01/01/2015 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Bavarian Nordic A/S
 Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IQVIA Partners A/S
 IQVIA Partners A/S Information Technology ServicesTechnology Services Operates an IT company | Technology Services |
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals | Health Technology |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardinal Health Specialty Solutions | |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
